Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes.

Diabetes - 1 Feb 2010

Pawson Elizabeth J, Duran-Jimenez Beatriz, Surosky Richard, Brooke Heather E, Spratt S Kaye, Tomlinson David R, Gardiner Natalie J

Abstract excerpt

OBJECTIVE: The objectives of the study were to evaluate retrograde axonal transport of vascular endothelial growth factor A (VEGF-A) protein to sensory neurons after intramuscular administration of an engineered zinc finger protein activator of endogenous VEGF-A (VZ+434) in an experimental model...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus, Experimental
Share to Functional Laterality
Share to Ganglia, Spinal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Engineering

Share to Image Enhancement

Share to Rats, Wistar

Share to Sensory Receptor Cells

Share to Zinc Fingers

Source

Open in PubMed Open full text

Identifiers

PMID: 19934008
DOI: 10.2337/db08-1526
PMCID: PMC2809974

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19934008-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes.PMID 19934008Read ↗

An optimized low-dose streptozotocin protocol enables rapid induction of diabetic neuropathy with high survival in ratsSemantic proximity Read ↗

Effects of Topical Application of CHF6467, a Mutated Form of Human Nerve Growth Factor, on Skin Wound Healing in Diabetic Mice.Semantic proximity Read ↗

Enhancing therapeutic potential: Human adipose‐derived mesenchymal stem cells modified with recombinant adeno‐associated virus expressing VEGF165 gene for peripheral nerve injurySemantic proximity Read ↗

An optimized low-dose STZ model rapidly induces diabetic neuropathy in ratsSemantic proximity Read ↗

Neuron-derived neurotrophic factor functions as a novel modulator that enhances endothelial cell function and revascularization processes.Semantic proximity Read ↗

Nerve Growth Factor Gene Therapy Using Adeno-Associated Viral Vectors Prevents Cardiomyopathy in Type 1 Diabetic MiceSemantic proximity Read ↗

Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback.Semantic proximity Read ↗

Caveolin-1 and altered neuregulin signaling contribute to the pathophysiological progression of diabetic peripheral neuropathy.Semantic proximity Read ↗

Vasoinhibin Gene Transfer by Adenoassociated Virus Type 2 Protects against VEGF- and Diabetes-Induced Retinal VasopermeabilitySemantic proximity Read ↗

Intravenous streptozotocin induces variants in painful diabetic peripheral neuropathy in female miceSemantic proximity Read ↗

Atf3 mutant mice show reduced axon regeneration and impaired regeneration-associated gene induction after peripheral nerve injury.Semantic proximity Read ↗

Expression of macrophage migration inhibitory factor in footpad skin lesions with diabetic neuropathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.